{'52WeekChange': -0.7170909,
 'SandP52WeekChange': None,
 'address1': '9540 Towne Centre Drive',
 'address2': 'Suite 100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.8491,
 'askSize': 900,
 'averageDailyVolume10Day': 82926912,
 'averageVolume': 20433704,
 'averageVolume10days': 82926912,
 'beta': None,
 'beta3Year': None,
 'bid': 0.86,
 'bidSize': 1200,
 'bookValue': -0.112,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.05,
 'dayLow': 0.825,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.951,
 'enterpriseToRevenue': 8.872,
 'enterpriseValue': 83509392,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '858 888 7601',
 'fiftyDayAverage': 0.54914284,
 'fiftyTwoWeekHigh': 4.7,
 'fiftyTwoWeekLow': 0.25,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 81579689,
 'forwardEps': -0.25,
 'forwardPE': -3.56,
 'fromCurrency': None,
 'fullTimeEmployees': 97,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.10414,
 'heldPercentInstitutions': 0.11256,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/bionanogenomics.com',
 'longBusinessSummary': 'Bionano Genomics, Inc. operates as a life sciences '
                        'instrumentation company in the genome analysis space. '
                        'The company develops and markets the Saphyr system, a '
                        'platform for ultra-sensitive and ultra-specific '
                        'structural variation detection that enables '
                        'researchers and clinicians to accelerate the search '
                        'for new diagnostics and therapeutic targets, and to '
                        'streamline the study of changes in chromosomes, which '
                        'is known as cytogenetics. Its Saphyr system includes '
                        'an instrument, chip consumables, reagents, and a '
                        "suite of data analysis tools. The company's Bionano "
                        'prep kits and labeling kits provide the critical '
                        'reagents and protocols needed to extract and label '
                        'high molecular weight DNA for use with the Saphyr '
                        'system; and data solutions offering includes a suite '
                        'of hardware and software for end-to-end experiment '
                        'management, algorithms for assembling genome maps, '
                        'and algorithms and databases for bioinformatics '
                        'processing. It sells its products for research use '
                        'applications primarily to laboratories associated '
                        'with academic and governmental research institutions, '
                        'as well as to pharmaceutical, biotechnology, and '
                        'contract research companies in the United States and '
                        'Canada, Europe, the Middle East, India, Africa, '
                        'China, Japan, South Korea, Singapore, and Australia. '
                        'The company was formerly known as BioNano Genomics, '
                        'Inc. and changed its name to Bionano Genomics, Inc. '
                        'in July 2018. Bionano Genomics, Inc. was founded in '
                        '2003 and is headquartered in San Diego, California.',
 'longName': 'Bionano Genomics, Inc.',
 'market': 'us_market',
 'marketCap': 74684352,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_5900432',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -32473070,
 'nextFiscalYearEnd': 1640908800,
 'open': 0.9009,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '858 888 7600',
 'previousClose': 0.778,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 7.9345856,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.05,
 'regularMarketDayLow': 0.825,
 'regularMarketOpen': 0.9009,
 'regularMarketPreviousClose': 0.778,
 'regularMarketPrice': 0.9009,
 'regularMarketVolume': 127001610,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 83915000,
 'sharesPercentSharesOut': 0.0471,
 'sharesShort': 3952943,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 4150389,
 'shortName': 'Bionano Genomics, Inc.',
 'shortPercentOfFloat': 0.047199998,
 'shortRatio': 0.33,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'BNGO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.523,
 'twoHundredDayAverage': 0.65633094,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'b62a5cf8-b7ae-336a-8f8b-f6a25125d0d8',
 'volume': 127001610,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.bionanogenomics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92121'}